CD4 and diabetes mellitus: The increased activation of this axis in diabetes, also as shown in Figure 3, suggests a heightened role for adaptive immunity, where CD4+ T cells, particularly the Th17 subset, exacerbates the fibrotic response by sustaining inflammation and promoting the activation of HSCs.